Delivery Order SPE2DR25D3016-SPE2DR26FG2CG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Cetirizine-Pseudoephedrine ER 5-120 mg tablets in packages of 24 units, with a contract ceiling value of $5,052.33. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and no set-aside designation was used. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,268.45 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Cetirizine HCL 5 mg tablets (100 count). The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,979.76 to AmerisourceBergen Drug Corp for the supply of Cetirizine-Pseudoephedrine Extended Release 5-120 mg tablets (24-count packages). This non-set-aside, firm fixed price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Cetirizine-Pseudoephedrine Extended Release 5-120 mg tablets in quantities of 24 units. This firm fixed price delivery order, valued at $1,355.54, represents a non-competitive set-aside and supports federal pharmaceutical procurement needs. The contract is scheduled for completion by August 11, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Cetirizine HCl 10 mg tablets (300-count) with a ceiling value of $1,632.98. This firm fixed-price delivery order is set to be completed by October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is issued under a non-set-aside, competitively awarded procurement process and represents a child contract action...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $5,565.77. This is a firm fixed-price delivery order executed under a non-set-aside competitive procurement, with an ultimate completion date of December 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,394.77 for 500 tablets of Cetirizine HCL 10 mg on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,218.70 for Cetirizine HCL 5 mg tablets (100-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,834.09 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,676.64 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2CGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,698.47 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Cetirizine-Pseudoephedrine ER 5-120 mg tablets in quantities of 12 units. The contract, designated as non-set-aside and utilizing firm fixed-price terms, is scheduled for completion by December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for over-the-counter allergy and decongestant medication represents routine pharmaceutical fulfillment under the broader contract vehicle, supporting DLA's mission to supply medical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/9/25 |